cgp 42112a has been researched along with D-fructopyranose in 1 studies
Studies (cgp 42112a) | Trials (cgp 42112a) | Recent Studies (post-2010) (cgp 42112a) | Studies (D-fructopyranose) | Trials (D-fructopyranose) | Recent Studies (post-2010) (D-fructopyranose) |
---|---|---|---|---|---|
233 | 0 | 35 | 18,095 | 1,041 | 5,633 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hsieh, PS | 1 |
1 other study(ies) available for cgp 42112a and D-fructopyranose
Article | Year |
---|---|
Reversal of fructose-induced hypertension and insulin resistance by chronic losartan treatment is independent of AT2 receptor activation in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Antihypertensive Agents; Fructose; Glucose; Glucose Clamp Technique; Hypertension; Imidazoles; Insulin Resistance; Liver; Losartan; Male; Oligopeptides; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2 | 2005 |